Thus, to understand if increased UBC9 expression is accompanied by enhanced PML-NBs biogenesis in ccRCC cells, we compared the recovery time of PML-NBs formation upon PML degradation by arsenic trioxide (ATO). This evidence concerns the gene UBE2I and nonpapillary renal cell carcinoma.